$MDAIW News

Last published 1d ago

1d agoMDAI MDAIWSpectral AI Announces 2026 Third Quarter Financial ResultsGlobeNewswireRemains on Track for First U.S. Commercial Placement of the DeepView AI System in the Fourth Quarter of 2026
2w agoMDAI MDAIWSpectral AI Schedules 2026 Third Quarter Financial Results and Conference CallGlobeNewswireDALLAS, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more
4w agoMDAI MDAIWSpectral AI’s DeepView™ System Showcased at the 2026 American College of Emergency Physicians (ACEP) Scientific AssemblyGlobeNewswireDALLAS, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more
1mo agoMDAI MDAIWSpectral AI Showcases DeepView® System for Burn Indication and KOL Research at Southern Regional Burn ConferenceGlobeNewswireDALLAS, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more
2mo agoMDAI MDAIWSpectral AI to Present at H.C. Wainwright 28th Annual Global Investment ConferenceGlobeNewswireDALLAS, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence company focused on medical diagnostics for faster and more
3mo agoMDAI MDAIWSpectral AI Schedules 2026 Second Quarter Financial Results and Conference CallGlobeNewswireDALLAS, July 29, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more
4mo agoMDAI MDAIWSpectral AI Names Darcy Bajko Chief Commercial Officer to Lead Global Sales Launch of FDA-Cleared DeepView® System for Burn IndicationGlobeNewswireDALLAS, July 08, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more
4mo agoMDAI MDAIWDeepView® System Highlighted at the 2026 British Burn Association Annual ConferenceGlobeNewswireDALLAS, June 25, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more
5mo agoMDAI MDAIWSpectral AI Joins the American Board of Wound Management Foundation in Celebrating Wound Healing Awareness MonthGlobeNewswireDALLAS, June 12, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment
5mo agoMDAI MDAIWSpectral AI to Participate in 2026 British Burn Association Annual ConferenceGlobeNewswireDALLAS, June 11, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment
5mo agoMDAI MDAIWSpectral AI Announces Voting Results of Annual Meeting of StockholdersGlobeNewswireDALLAS, June 01, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment
5mo agoMDAI MDAIWSpectral AI Receives FDA De Novo Clearance for DeepView® System for Burn IndicationGlobeNewswireDALLAS, May 26, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment
6mo agoMDAI MDAIWSpectral AI Announces 2026 First Quarter Financial ResultsGlobeNewswireDevelopment Work for DeepView® Systems Continues with Support of Recently Awarded $31.7 Million of Funding from BARDA Reiterates Annual Revenues Guidance DALLAS, May 12, 2026 (GLOBE NEWSWIRE) -- Spectral AI,
6mo agoMDAI MDAIWSpectral AI Wins Small Business Innovator Award at Inaugural Texas Innovation ConferenceGlobeNewswireDALLAS, April 30, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment
6mo agoMDAI MDAIWSpectral AI Schedules 2026 First Quarter Financial Results and Conference CallGlobeNewswireDALLAS, April 28, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment
6mo agoMDAI MDAIWSpectral AI's DeepView® System Showcased at 2026 American Burn Association Annual MeetingGlobeNewswireDALLAS, April 22, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment
6mo agoMDAI MDAIWSpectral AI Announces Annual Meeting of StockholdersGlobeNewswireDALLAS, April 20, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment
7mo agoMDAI MDAIWSpectral AI to Feature DeepView® System at 2026 American Burn Association Annual MeetingGlobeNewswireDALLAS, April 09, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment
7mo agoMDAI MDAIWSpectral AI Names David McGuire, CPA, as Chief Financial OfficerGlobeNewswireDALLAS, April 08, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment
7mo agoMDAI MDAIWSpectral AI Announces 2025 Fourth Quarter and Full Year Financial Results and Introduces Revenue Guidance for 2026GlobeNewswireOverview Full Year Research & Development Revenue of $19.7 Million; Q4 2025 Revenue of $3.8 MillionCash Rose to $15.4 Million at December 31, 2025 DALLAS, March 24, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc.
8mo agoMDAI MDAIWSpectral AI Schedules 2025 Fourth Quarter and Full Year Financial Results and Conference CallGlobeNewswireDALLAS, March 10, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment
9mo agoMDAI MDAIWSpectral AI Names Vincent S. Capone as Chief Executive OfficerGlobeNewswireDALLAS, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment
9mo agoMDAI MDAIWSpectral AI to Participate in National Burn Awareness Week 2026 February 1–7, 2026GlobeNewswireDALLAS, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment
11mo agoMDAI MDAIWDeepView™ System Featured at 2025 US Burn ConferencesGlobeNewswireDALLAS, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment
1y agoMDAI MDAIWSpectral AI Announces 2025 Third Quarter Financial ResultsGlobeNewswireQ3 Overview Research & Development Revenue of $3.8 Million; $15.6 Million in YTD Revenue for 2025Strong Cash position of $10.5 Million and progress toward FDA De Novo submission DALLAS, Nov. 11, 2025 (GLOBE
1y agoMDAI MDAIWSpectral AI Schedules 2025 Third Quarter Financial Results and Conference CallGlobeNewswireDALLAS, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment
1y agoMDAI MDAIWSpectral AI raises $7.6 Million of Additional Growth CapitalGlobeNewswireDALLAS, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment
1y agoMDAI MDAIWSpectral AI Named to TIME's List of World's Top HealthTech Companies 2025GlobeNewswireDALLAS, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment
1y agoMDAI MDAIWDeepView® System highlighted at the European Burns Association CongressGlobeNewswireDALLAS, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment
1y agoMDAI MDAIWSpectral AI Announces 2025 Second Quarter Financial ResultsGlobeNewswireQ2 Overview Research & Development Revenue of $5.1 Million, total revenue for the first half of 2025 of $11.8 MillionStrong Cash position of $10.5 MillionSubmission of De Novo application to FDA completed in Second
1y agoMDAI MDAIWSpectral AI Schedules 2025 Second Quarter Financial Results and Conference CallGlobeNewswireDALLAS, July 30, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ:MDAI) ("Spectral AI" or the "Company"), developer of the AI-driven DeepView® System and focused on medical diagnostics for faster and more accurate
1y agoMDAI MDAIWSpectral AI Announces Submission to FDA of its DeepView® SystemGlobeNewswireDALLAS, June 30, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ:MDAI) ("Spectral AI" or the "Company"), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from the U.S. Food
1y agoMDAI MDAIWDeepView® System highlighted at the annual British Burn Association conferenceGlobeNewswireDALLAS, June 10, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment
1y agoMDAI MDAIWSpectral AI Announces Appointment of Stanley Micek as Chief Operating OfficerGlobeNewswireDALLAS, May 30, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment
1y agoMDAI MDAIWSpectral AI Announces Voting Results from 2025 Annual Meeting of StockholdersGlobeNewswireDALLAS, May 29, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment
1y agoMDAI MDAIWDeepView® System Achieves 95.3% Accuracy Evaluation as Published in Burns JournalGlobeNewswireDALLAS, May 27, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), a leading developer of the AI-driven DeepView® System, which uses multi-spectral imaging and AI algorithms
1y agoMDAI MDAIWSpectral AI Research Partner Using DeepView System Wins Best Research Project at the 2025 Education AwardsGlobeNewswireDALLAS, May 20, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), a leading developer of the AI-driven DeepView® System, which uses multi-spectral imaging and AI algorithms
1y agoMDAI MDAIWSpectral AI Announces 2025 First Quarter Financial ResultsGlobeNewswireQ1 Overview Research & Development Revenue of $6.7 MillionImproved Capital Structure Reflected in Cash of $14.1 MillionContinued work on planned De Novo submission to the FDA in the first half of 2025 DALLAS, May
1y agoMDAI MDAIWSpectral AI Schedules 2025 First Quarter Financial Results and Conference CallGlobeNewswireDALLAS, May 02, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), a leading developer of the AI-driven DeepView® System, which uses multi-spectral imaging and AI algorithms
1y agoMDAI MDAIWBurn clinicians present positive findings of the DeepView® System's accuracy at the American Burn Association annual meetingGlobeNewswireDALLAS, April 30, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), a leading developer of the AI-driven DeepView® System, which uses multi-spectral imaging and AI
1y agoMDAI MDAIWSpectral AI Announces 2024 Fourth Quarter and Full Year Financial ResultsGlobeNewswire2024 Research & Development Revenue of $30 Million Successful Results from the US Burn Validation Study On Track for Regulatory Submission in US for DeepView™ System
1y agoMDAI MDAIWSpectral AI Raises up to $15 Million of Debt Financing and Strengthens Financial Position for U.S. CommercializationGlobeNewswireDALLAS, March 24, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), a leading developer of the AI-driven DeepView® System, which uses multi-spectral imaging
1y agoMDAI MDAIWSpectral AI Announces Public Filing of Registration Statement for Proposed Initial Public Offering of Spectral IPGlobeNewswireDALLAS, March 20, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ:MDAI) ("Spectral AI" or the "Company"), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from the U.S. Food
1y agoMDAI MDAIWSpectral AI Announces Successful Results from its Burn Validation Study of the DeepView SystemGlobeNewswireDeepView® System outperforms burn physicians in identifying non-healing tissue Landmark Burn Validation Study, one of the largest in U.S. history, confirms DeepView's performanceSpectral AI plans FDA submission by
1y agoMDAI MDAIWSpectral AI Completes Three Device Installations in AustraliaGlobeNewswireDALLAS, March 06, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ:MDAI) ("Spectral AI" or the "Company"), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from the U.S. Food
1y agoMDAI MDAIWCORRECTION: Spectral AI Schedules 2024 Fourth Quarter and Full Year Financial Results and Conference CallGlobeNewswireDALLAS, Feb. 28, 2025 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Spectral AI, Inc. (NASDAQ:MDAI), the reporting date of the financial results for the fourth quarter was incorrectly
1y agoMDAI MDAIWSpectral AI Schedules 2024 Fourth Quarter and Full Year Financial Results and Conference CallGlobeNewswireDALLAS, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ:MDAI) ("Spectral AI" or the "Company"), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from the U.S. Food
1y agoMDAI MDAIWSpectral AI Strengthens Financial Position Ahead of FDA SubmissionGlobeNewswireDALLAS, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ:MDAI) ("Spectral AI" or the "Company"), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from the U.S. Food
1y agoMDAI MDAIWSpectral AI Completes Data Analysis for U.S. Burn Pivotal StudyGlobeNewswireDALLAS, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ:MDAI) ("Spectral AI" or the "Company"), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from the U.S. Food
1y agoMDAI MDAIWSpectral AI Completes Pediatric Enrollment in Emergency Departments for U.S. Burn Pivotal StudyGlobeNewswireDALLAS, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ:MDAI) ("Spectral AI" or the "Company"), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from the U.S. FDA